Friday 6 November 2026
Export INNV’s income statement to Excel — free account
InnovAge Holding Corp.
INNV Healthcare Medical Care Facilities
InnovAge Holding Corp.’s revenue for fiscal 2026 (year ended June 2026) was $989.7 million, up 15.9% from fiscal 2025.
- Revenue
- +12.1%
- EPS
- +155.0%
- Free cash flow
- +622.8%
- Total debt
- −16.7%
Quarter to September 2026, against a year earlier
9.04
0.75
−7.66%
Follow INNV
Alert me
| Jun '17 | Jun '19 | Jun '20 | Jun '21 | Jun '22 | Jun '23 | Jun '24 | Jun '25 | Jun '26 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | 5 | 4 | 3 | 4 | 6 | 6 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | 9.83 | 3.18 | 3.28 | 2.65 | 2.23 | 4.58 |
P/S ratio |
— | 4.64 | 4.64 | 4.13 | 0.85 | 1.48 | 0.90 | 0.59 | 1.62 |
Altman Z″-Score (non-manufacturers) |
— | 2.03 | 3.17 | 3.91 | 3.21 | 1.18 | 0.80 | 0.00 | 0.32 |
P/FCF ratio |
— | 141.37 | 141.37 | 0.00 | 0.00 | 0.00 | 0.00 | 21.57 | 31.73 |
Beneish M-Score |
— | — | (2.82) | (3.03) | (2.45) | (3.27) | (1.45) | (3.32) | (3.10) |
P/Operating CF |
— | 162.85 | 162.85 | 277.88 | 183.03 | 77.33 | 365.69 | 55.50 | 75.53 |
P/B ratio |
— | 0.00 | 0.00 | 7.73 | 1.75 | 3.37 | 2.47 | 2.10 | 6.73 |
Price to Tangible BV |
— | 0.00 | 0.00 | 12.53 | 2.85 | 5.89 | 5.15 | 5.43 | 17.20 |
EV/Sales |
— | 5.01 | 5.01 | 3.94 | 0.70 | 1.34 | 0.86 | 0.54 | 1.54 |
EV/EBITDA |
— | 113.77 | 113.77 | 2,478.95 | 49.32 | 0.00 | 0.00 | 0.00 | 62.08 |
EV/Operating CF |
— | 70.60 | 70.60 | (332.69) | 17.97 | 45.72 | (17.89) | 14.02 | 23.53 |
EV/FCF |
— | 152.51 | 152.51 | (100.09) | (34.13) | (141.15) | (13.68) | 19.90 | 30.05 |
Quick Ratio |
— | 1.39 | 2.12 | 3.08 | 2.16 | 1.33 | 1.11 | 0.88 | 0.92 |
Current Ratio |
— | 1.43 | 2.18 | 3.19 | 2.29 | 1.45 | 1.25 | 1.07 | 1.05 |
Net Debt/EBITDA |
— | 2.66 | 1.62 | (121.57) | (10.36) | 2.73 | 6.52 | 3.94 | (3.47) |
Debt/Assets |
0.00% | 53.16% | 52.84% | 15.15% | 14.66% | 14.41% | 14.25% | 12.76% | 10.10% |
Debt/Equity |
— | 2.37 | 2.01 | 0.24 | 0.24 | 0.27 | 0.28 | 0.28 | 0.24 |
Asset Turnover |
— | 2.56 | 1.47 | 1.36 | 1.29 | 1.23 | 1.37 | 1.59 | 1.83 |
Operating CF/Net income |
— | 1.32 | 1.67 | 0.17 | (4.19) | (0.50) | 1.73 | (1.08) | (25.51) |
Capex/Depreciation |
— | (1.46) | (0.99) | (1.46) | (2.66) | (1.47) | (0.41) | (0.31) | (0.48) |
Interest Coverage |
— | 4.14 | 3.48 | (0.73) | (1.74) | (32.45) | (5.76) | (6.45) | 0.61 |
| — | 22.35% | 27.78% | (19.60%) | (1.92%) | (12.70%) | (7.36%) | (11.76%) | (1.06%) | |
| — | 10.78% | 6.80% | (9.34%) | (1.20%) | (7.24%) | (3.83%) | (5.64%) | (0.47%) | |
ROIC |
— | 11.62% | 15.18% | (3.54%) | (1.17%) | (14.68%) | (5.73%) | (9.34%) | 1.06% |
Return on Tangible Assets |
— | 14.27% | 13.63% | (13.96%) | (2.09%) | (15.71%) | (9.38%) | (16.90%) | (1.44%) |
Average Days of Receivables |
— | 43.12 | 30.92 | 21.74 | 22.29 | 13.05 | 24.58 | 16.97 | 16.84 |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 13.90% | 13.66% | 24.23% | 18.01% | 19.66% | 17.84% | 17.60% | 20.29% |
Intangible Assets out of Total Assets |
0.00 | 0.34 | 0.30 | 0.25 | 0.23 | 0.23 | 0.26 | 0.28 | 0.26 |
Share Based Compensation of Revenue |
— | 0.16% | 0.10% | 0.26% | 0.54% | 0.67% | 0.89% | 0.89% | 0.71% |
Graham Net Nets |
— | 0.04 | 0.04 | 0.02 | 0.04 | (0.05) | (0.14) | (0.23) | (0.06) |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (0.74%) | (0.74%) | (1.73%) | (0.91%) | (4.13%) | (3.17%) | (6.23%) | (0.17%) |
Free Cash Flow Yield |
— | 0.71% | 0.71% | (0.95%) | (2.42%) | (0.64%) | (7.04%) | 4.64% | 3.15% |
Revenue per Share |
— | 3.52 | 4.28 | 5.16 | 5.16 | 5.07 | 5.62 | 6.31 | 7.29 |
Operating CF per Share |
— | 0.20 | 0.33 | (0.06) | 0.20 | 0.15 | (0.27) | 0.24 | 0.48 |
Capex per Share |
— | (0.11) | (0.09) | (0.16) | (0.28) | (0.17) | (0.06) | (0.05) | (0.08) |
Free Cash Flow per Share |
— | 0.09 | 0.24 | (0.22) | (0.08) | (0.02) | (0.33) | 0.20 | 0.40 |
Cash per Share |
— | 0.46 | 0.86 | 1.65 | 1.36 | 1.28 | 0.76 | 0.78 | 1.04 |
Shareholders Equity per Share |
— | 0.62 | 0.81 | 2.76 | 2.50 | 2.23 | 2.04 | 1.76 | 1.76 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.62 | 0.81 | 2.76 | 2.50 | 2.23 | 2.04 | 1.76 | 1.76 |
Free Cash Flow |
— | 11.42 | 32.15 | (27.09) | (10.94) | (3.12) | (44.81) | 26.60 | 54.12 |
Working Capital |
— | 35.99 | 90.30 | 172.37 | 135.65 | 66.78 | 34.54 | 11.30 | 10.42 |
Capital Expenditures |
— | (14.49) | (11.67) | (19.54) | (38.24) | (23.35) | (7.91) | (6.26) | (10.59) |
Net Current Asset Value |
— | (162.34) | (134.95) | 60.16 | 23.83 | (50.04) | (96.91) | (112.84) | (104.32) |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 581.74 |
Capex to Sales |
— | 0.03 | 0.02 | 0.03 | 0.05 | 0.03 | 0.01 | 0.01 | 0.01 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 614.22 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.10 | 0.12 | 0.09 | 0.08 | 0.08 | 0.10 | 0.12 | 0.13 |
Cash ROIC |
— | 3.40% | 7.33% | (4.33%) | (1.81%) | (0.56%) | (9.78%) | 6.47% | 12.40% |
Accounts Receivable Turnover |
— | 9.04 | 11.01 | 14.83 | 17.33 | 20.46 | 20.09 | 18.74 | 23.19 |
Accounts Payable Turnover |
— | 11.99 | 14.38 | 15.15 | 13.59 | 11.12 | 11.45 | 10.59 | 7.93 |
Inventory Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
— | 31.21 | 24.75 | 25.47 | 32.76 | 34.17 | 32.04 | 40.02 | 55.26 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 51.53 | 51.53 | 43.02 | 40.33 | 33.64 | 38.02 | 45.56 | 42.67 |
Average Payables |
— | 29.61 | 29.61 | 30.62 | 41.46 | 52.75 | 55.20 | 66.10 | 96.05 |
Average Assets |
— | 181.62 | 386.43 | 470.69 | 543.67 | 561.48 | 557.51 | 537.26 | 542.12 |
Average Common Equity |
— | 87.60 | 94.60 | 224.36 | 339.72 | 320.28 | 289.85 | 257.75 | 238.33 |
Columns are period end dates · fundamentals updated 5 Nov 2026